Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization of the ClinicalTrials.gov data ingest has been postponed from June 2025 to July 2025, and the revision number has been updated from v2.16.3 to v2.16.4.
    Difference
    0.9%
    Check dated 2025-06-20T17:50:58.000Z thumbnail image
  2. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:46:37.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.1 to v2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:25:21.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    1.0%
    Check dated 2025-05-30T00:13:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:20:18.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page has removed a significant publication reference regarding the 4-year results of a phase 3 trial comparing adjuvant nivolumab and ipilimumab for melanoma, which is a core aspect of the content.
    Difference
    0.2%
    Check dated 2025-05-15T19:26:26.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.